Search results
Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates
Zacks via Yahoo Finance· 2 days agoIntellia's (NTLA) earnings and revenues surpass estimates in the first quarter of 2024. The company...
Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
The Pilot News· 3 days agoSpyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ:SYRE), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic ...
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoOPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript May 7, 2024 OPKO Health, Inc. misses...
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript May 8, 2024...
NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual...
Digital Journal· 4 days ago(NASDAQ:NRXP) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically ...
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
The Grass Valley Union· 3 days agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today reported ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days ago“In the first quarter, we made solid progress across three key business priorities – clarifying the road ahead for AMT-130 in Huntington’s disease, initiating three new Phase I/II clinical ...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on...
NBC 10 - FOX 14 Monroe· 4 days agoNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will participate in the ...
Zevra Therapeutics Inc (ZVRA) Q1 2024 Earnings: Misses EPS Estim
Guru Focus· 4 days agoRevenue: Reported Q1 2024 revenue of $3.4 million, up from $3.2 million in Q1 2023, slightly below the estimated $3.76 million.Net Loss: Q1 2024 net loss widen
Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
Quad-City Times· 4 days agoRyan Confer Appointed Genprex President and CEO and to its Board of Directors